Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1295-1296, 2010-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Thiomersal in Vaccines: Is Removal Warranted?
By Clements C.
Drug Safety, Vol. 24, Iss. 8, 2001-01 ,pp. :
Access to resources
Recommend
Off-label or untested use of drug-eluting stents warranted?
Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. :
Evaluating EVR to PEG IFN-α-2b/ribavirin therapy worthwhile
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 491, 2005-01 ,pp. :
PEG IFN- -2b + ribavirin: 24 weeks sufficient for HCV-2 and HCV-3?
Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. :
Lamivudine plus IFN- -2b: potential in hepatitis B?
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :